Prestige Consumer Healthcare Inc. SEC filings PBH
Prestige Consumer Healthcare Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 6, 2008. Its latest annual report, Form ARS, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF LETTER | Filing | Sep 26, 2019 | — |
| SEC STAFF LETTER | Filing | Sep 12, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2016 | — |
| CORRESP | Letter to the SEC | Mar 3, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2016 | — |
| 11-K | Employee savings plan report | Jun 25, 2013 | Mar 31, 2013 |
| UPLOAD | Letter from the SEC | May 6, 2013 | — |
| CORRESP | Letter to the SEC | Apr 24, 2013 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2013 | — |
| CORRESP | Letter to the SEC | Mar 12, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2013 | — |
| EFFECT | Filing | Jul 13, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2012 | — |
| CT ORDER | Filing | Jun 6, 2012 | — |
| CORRESP | Letter to the SEC | May 18, 2012 | — |
| DFAN14A | Filing | May 10, 2012 | — |
| UPLOAD | Letter from the SEC | May 9, 2012 | — |
| SC TO-C | Schedule to-c | May 4, 2012 | — |
| SC14D9C | Filing | May 3, 2012 | — |
| SC TO-C | Schedule to-c | Apr 30, 2012 | — |
| SC14D9C | Form sc14d9c | Apr 27, 2012 | — |
| DFAN14A | Filing | Apr 27, 2012 | — |
| SC TO-C | Schedule to-c | Apr 27, 2012 | — |
| PREC14A | Form prec14a | Apr 25, 2012 | — |
| SC TO-C | Filing | Apr 5, 2012 | — |
| DFAN14A | Direct and indirect interests filing | Apr 4, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2012 | — |
| SC14D9C | Filing | Mar 22, 2012 | — |
| SC14D9C | Filing | Mar 22, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2012 | — |
| CORRESP | Letter to the SEC | Mar 16, 2012 | — |
| SC TO-C | Filing | Mar 16, 2012 | — |
| DFAN14A | Schedule 14a | Mar 16, 2012 | — |
| SC14D9C | Form sc14d9c | Mar 16, 2012 | — |
| SC TO-C | Schedule to-c | Mar 15, 2012 | — |
| SC14D9C | Form sc14d9c | Mar 13, 2012 | — |
| SC TO-C | Scedule to-c | Mar 12, 2012 | — |
| CERTNYS | Auto-generated paper document | Mar 7, 2012 | — |
| 8-A12B | Registration | Feb 28, 2012 | — |
| SC TO-C | To-c | Feb 27, 2012 | — |
| CORRESP | Letter to the SEC | Feb 21, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2012 | — |
| CT ORDER | Filing | Jan 18, 2012 | — |
| EFFECT | Filing | Aug 4, 2011 | — |
| CORRESP | Letter to the SEC | Aug 2, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2011 | — |
| CT ORDER | Filing | Jun 1, 2011 | — |
| EFFECT | Filing | Aug 18, 2010 | — |
| CORRESP | Letter to the SEC | Aug 16, 2010 | — |
| CORRESP | Letter to the SEC | Aug 16, 2010 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2010 | — |
| UPLOAD | Letter from the SEC | May 14, 2010 | — |
| CORRESP | Letter to the SEC | Apr 8, 2010 | — |
| CORRESP | Letter to the SEC | Mar 15, 2010 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2010 | — |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PBH (NYSE)
- Fiscal year ends
- March 31
- Headquarters
- Tarrytown, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1295947
- Former names
- Prestige Brands Holdings, Inc. (until Aug 10, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.